The UK Dementia Research Institute (UK DRI): Five years of innovation in discovery science🧠🧪🔬 📽️ Who we are👉https://buff.ly/3UVRiDa 📖 What we do & how we do it👉 https://buff.ly/3GwWmts 📩 Sign up for our monthly newsletter👉 https://buff.ly/3QdFXN4
UK Dementia Research Institute
Research
London, England 16,195 followers
New scientific discoveries, new hope to stop dementia. Come join our hundreds of researchers and staff.
About us
The national UK Dementia Research Institute (UK DRI) is the single biggest investment in dementia research in the UK. Established in 2017 by the Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK, the £290million institute is located across six leading UK universities: University of Cambridge, Cardiff University, University of Edinburgh, Imperial College London and King’s College London, with its central hub at UCL. The UK DRI accelerates discoveries to prevent, treat and care for people with all types of dementia, and it will help us understand ways to keep the brain healthy. The UK DRI attracts the brightest minds in research, both in the UK and globally, and will ultimately be made up of 700 researchers, continuing to make the UK one of the best places in the world to study neuroscience. More info: www.ukdri.ac.uk
- Website
-
http://www.ukdri.ac.uk
External link for UK Dementia Research Institute
- Industry
- Research
- Company size
- 501-1,000 employees
- Headquarters
- London, England
- Type
- Public Company
- Founded
- 2017
- Specialties
- science and research
Locations
-
Primary
Get directions
UK DRI HQ, 6th Floor Maple House
Tottenham Court Road
London, England W1T 7NF, GB
Employees at UK Dementia Research Institute
Updates
-
The UK DRI's Dr Nir Grossman is developing a headset that can stimulate areas deep within the brain without surgery. He is testing whether a technique called temporal interference could help improve symptoms of dementia. Dr Grossman spoke to Alzheimer's Society about how the integral role people living with Alzheimer's are playing in his research👉https://buff.ly/3AfjTy3
-
-
Dr Shlomi Haar (UK DRI Care Research & Technology) is developing #DigitalBiomarkers that can provide cost-effective, objective, and robust measures to track progression of neurodegenerative disease. Hear more about his work⬇️📽️
-
How close are we to a blood test for Alzheimer's? The UK DRI's Prof Tara Spires-Jones, along with Prof Jonathan Schott (UCL) & other experts, spoke to Nature about recent developments in blood biomarker research ⬇️
Blood tests could soon predict your risk of Alzheimer’s
nature.com
-
Last week the Lancet Commission's new report concluded that addressing 14 risk factors could prevent or delay nearly half of dementia cases. The report revealed two new risk factors - vision loss and high cholesterol. Prof David Attwell, Director of the BHF-UK DRI Vascular Dementia Centre, commented: “I welcome this updated version of earlier Lancet Commission reports on dementia. Vascular contributions to dementia are given higher prominence compared to the 2020 report, with the recognition that vascular health and hence dementia risk can be negatively affected by diabetes, cholesterol level, hypertension, smoking, obesity, air pollution and head injury." UK DRI researchers respond to the report ⬇���
Comment: Lancet Commission report finds nearly half of dementia cases could be prevented or delayed
ukdri.ac.uk
-
New research by the UK DRI's Dr Tim Bartels introduces new iPSC "inclusionopathy" models, shedding light on α-synuclein inclusions. The team identified neuroprotective and neurotoxic inclusions, and studied their impact on survival of neurons👉https://buff.ly/3A7NDwv
-
-
What role does chemistry play in neurodegeneration? The UK DRI's Prof Karen Duff spoke to Chemistry World for a fascinating deep dive article on the biochemistry of Alzheimer's. Read more ⬇️
Brain chemistry basics
chemistryworld.com
-
Opportunity for a postdoc to join Dr Raja Nirujogi's lab at the MRC-PPU in Dundee, for a joint project with Prof Siddharthan Chandran / Dr @bhuvaneish Selvaraj at the UK DRI at Edinburgh! Develop blood-based biomarkers for MND/ALS using ultra-sensitive mass spec & proteogenomics 👉https://buff.ly/3WwbpKl
-
-
The Paris Brain Institute is opening its second call for applications for the startup studio program: NeurAL, to accelerate innovation in neuroscience. This seed funding program aims to identify and support neuroscience R&D projects, to help bring them to fruition and promote innovative entrepreneurship. It offers the winning projects personalised support as well as funding of up to €400,000, depending on the specific needs of each project for achieving its objectives. For more info and to apply ⬇️
Paris Brain Institute launches the 2nd edition of NeurAL, its studio startup program dedicated to neuroscience - Institut du Cerveau
https://institutducerveau-icm.org